ECCEUKCH: The First Year of Activities to Promote European Extra Virgin Olive Oil in the UK and Switzerland Comes to a Close March 31, 2026 The first year of ECCEUKCH – The Excellence of European Olive Growing in the UK and Switzerland, the three-year information and promotion programme dedicated to high-quality European extra virgin olive oil, co-financed by the European Union under Regulation (EU) No 1144/2014, has come to an end. Promoted by the Tuscan Association of Olive Growers OL.MA. [...]
Fresha Becomes the Software Infrastructure of Choice for Multi-location Selfcare Businesses as Enterprise Growth Surges March 31, 2026 Fresha, the top-rated AI-powered booking platform for beauty and wellness, is witnessing significant enterprise growth as multi-location and large-team businesses increasingly choose Fresha to manage and scale their operations. Leading well-established brands, including Menspire, Ted’s Grooming Room, Gould Barbers, Masaj, Adams Barbers, The Art of Nails, and more, are among a growing cohort of enterprise [...]
Thermochemical Energy Storage Leader Redoxblox Rebrands as Tempo March 31, 2026 Breaking the heat barrier: Tempo advances towards commercial rollout of continuously delivered electrified industrial heat at up to 1,200°C
Allshares Acquires Technology Company Amalia to Accelerate Innovation in Ownership and Incentive Management March 31, 2026 Allshares, a global equity and ownership management platform, today announced the acquisition of Amalia, a France-based company specializing in sales commission and performance management software. The acquisition strengthens Allshares’ platform, adding a sophisticated, rules-based engine that expands and enhances its end-to-end ownership offering. Founded in 2020, Amalia was built technology-first. Its software is centered on [...]
Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets March 31, 2026 Revenues of €1.8 billion (-4% versus PY) driven by solid performance across key therapeutic areas and global markets, partially offset by Ocaliva® withdrawal impact. Adjusted EBITDA2 of €350 million (-18% versus PY) underpinned by streamlined operational efficiencies and operating model evolution. Like-for-like Revenues up 7%, and EBITDA up 20%, adjusted for voluntarily withdrawal of Ocaliva® from US market. Marketing application under EMA review for the use of Jyseleca® in a new indication of axial spondyloarthritis (axSpA), a chronic inflammatory arthritis, to address unmet patient needs, submitted following the reporting period. Following the reporting period, agreement with GSK plc for worldwide exclusive rights to develop, manufacture and commercialise linerixibat; subsequently granted FDA approval for the US market (March 2026).
AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial March 31, 2026 Early biomarker and safety data show encouraging signals with plans to present additional data in 2H 2026 AviadoBio secures strategic investment from The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) through their Treat FTD Fund to support ASPIRE-FTD Trial AviadoBio regains full rights to AVB-101 gene therapy program
FuneralExperts.com Joins Forces with NotifyNOW and InheritNOW to Transform Support for Bereaved Families Across the UK March 31, 2026 FuneralExperts.com, the UK’s leading independent and impartial frontline bereavement support service, has announced a new partnership with The Estate Registry’s services NotifyNOW and InheritNOW to transform the way families are supported following a death – helping them notify organisations efficiently and access vital financial assistance before probate is granted. Through the partnership, families supported by [...]
Provation Introduces Real-Time, AI-Powered Documentation Assist for GI Procedures March 30, 2026 Provation, a leading provider of clinical productivity software, announces the launch of Provation® Mira Documentation Assist, a voice-driven documentation capability within its cloud-based GI procedure platform, Provation® Apex, enabling real-time structured documentation during procedures. This hands-free technology allows clinicians to document in real-time by simply speaking, reducing the need for manual data entry and post-procedure [...]
Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote March 30, 2026 Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased. Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks. Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority.
AngloGold Ashanti Holdings plc Announces Capped Cash Tender Offers for Part of Its 3.375% Notes Due 2028, 3.750% Notes Due 2030 and 6.500% Notes Due 2040 March 30, 2026 AngloGold Ashanti Holdings plc (the “Offeror”), a company incorporated under the laws of the Isle of Man, announces today the offers to purchase for cash the outstanding series of its (i) 3.375% notes due 2028 (the “2028 Notes”), (ii) 3.750% notes due 2030 (the “2030 Notes”) and (iii) 6.500% notes due 2040 (the “2040 Notes” [...]